Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM96XYI)

Drug Name

(S)-2-Amino-4-methyl-pentane-1-thiol Drug Info

Synonyms

CHEMBL448735; 88264-65-7; Leucinthiol; 2-Amino-4-methyl-pentane-1-thiol; L-LEUCINETHIOL; (S)-2-Amino-4-methyl-pentane-1-thiol; AC1L3ELJ; 1-Pentanethiol, 2-amino-4-methyl-, (2S)-; SCHEMBL2002339; GXEDNWSUKCJLLB-LURJTMIESA-N; ZINC403014; BDBM50078133; AKOS006342069; (S)-2-Amino-4-methyl-1-pentanethiol; (S)-2-Amino-4-methylpentane-1-thiol; (2S)-2-amino-4-methylpentane-1-thiol; 1-Pentanethiol, 2-amino-4-methyl-, (S)-; L-Leucinethiol, oxidized dihydrochloride, leucine aminopeptidase inhibitor

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 139311
CAS Number: CAS 88264-65-7
TTD Drug ID: DM96XYI

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Aminopeptidase N (ANPEP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
IP10 C8	DMANRGW	Psoriasis vulgaris	EA90	Phase 2	[2]
[(125)I] RB129	DMX0G7E	Discovery agent	N.A.	Investigative	[3]
KELATORPHAN	DMOX8FD	Discovery agent	N.A.	Investigative	[4]
(1-Amino-3-phenyl-propyl)-phosphinic acid	DMXD697	Discovery agent	N.A.	Investigative	[1]
N1-(3,3-diphenylpropyl)-N3-hydroxymalonamide	DM5F04D	Discovery agent	N.A.	Investigative	[5]
N1-(4-chlorobenzyl)-2-benzyl-N3-hydroxymalonamide	DMTMDZ4	Discovery agent	N.A.	Investigative	[5]
N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide	DM1L89K	Discovery agent	N.A.	Investigative	[5]
1-aminohexylphosphonic acid	DMFUABI	Discovery agent	N.A.	Investigative	[6]
(S)-2-Amino-3-phenyl-propane-1-thiol	DMMAUKO	Discovery agent	N.A.	Investigative	[1]
(Amino-phenyl-methyl)-phosphinic acid	DMS4ZVK	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Aminopeptidase N (ANPEP)	TTPHMWB	AMPN_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor. Bioorg Med Chem Lett. 1999 Jun 7;9(11):1511-6.
2	Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions. Clin Chem Lab Med. 2009;47(3):253-61.
3	Ontogenic and adult whole body distribution of aminopeptidase N in rat investigated by in vitro autoradiography. Biochimie. 2004 Feb;86(2):105-13.
4	Retro-inverso concept applied to the complete inhibitors of enkephalin-degrading enzymes. J Med Chem. 1988 Sep;31(9):1825-31.
5	Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents. J Med Chem. 2007 Mar 22;50(6):1322-34.
6	New aromatic monoesters of alpha-aminoaralkylphosphonic acids as inhibitors of aminopeptidase N/CD13. Bioorg Med Chem. 2010 Apr 15;18(8):2930-6.